A Parkinson's disease treatment based on induced pluripotent stem cells (iPS) has been officially approved in Japan – as announced by ...

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...

Japan's health ministry has announced formal approval for the domestic manufacture and sale of two products for the treatment of heart disease and Parkinson's disease using iPS cells. It means such ...

UAB radiologists provide high-quality subspecialty imaging support, helping fill gaps caused by radiologists’ shortage in resource-poor communities. The UAB team partners with Mbingo Baptist Hospital ...

Law firms behind cases aligned with Health Secretary Robert F. Kennedy Jr.’s Make America Healthy Again movement are eyeing a new litigation front.

The Japanese government on Friday conditionally approved the commercialization of two regenerative medicine products prepared from induced pluripotent ...

Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking cessation drug, despite the significant benefits of quitting.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2025 Earnings Call Transcript March 5, 2026 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.07.

Japan's health ministry said Friday it has conditionally approved production and sales of two novel regenerative therapies capitalizing on induced pluripotent stem cells. The world's first permission ...

Conditional approval marks a global milestone in regenerative medicine; treatments could reach patients this summer - Anadolu Ajansı ...